Skip to main content
Premium Trial:

Request an Annual Quote

LGC Acquires German DNA Testing Firm to Expand European Footprint

NEW YORK, May 15 (GenomeWeb News) - LGC, a provider of analytical and diagnostic services based in London, said on Friday that it has acquired the Institut f r Blutgruppenforschung, a DNA services provider based in Cologne, Germany.


IBF specializes in DNA services for paternity testing and forensic genetics, and is part of LGC's strategy "to expand its DNA analysis services into mainland Europe," the company said in a statement.


Financial terms of the acquisition were not disclosed.


IBF has a clinic with sampling facilities in D sseldorf and is "assessing options to expand into other areas of Germany," LGC said.


LGC's current operations in Germany include a facility for producing pharmaceutical impurity reference standards in Luckenwalde and a reference-material subsidiary called LGC Promochem in Wesel.


In January, LGC acquired AGOWA, a genomics company based in Berlin. LGC also has operations in the UK, France, Italy, Poland, Spain, Sweden, and India.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.